Drug Profile
Interferon alpha-2a biosimilar - Rhein Minapharm Biogenetics
Alternative Names: Hansenula-derived interferon alpha-2a; IFN-alpha-2a biosimilar - Rhein Minapharm Biogenetics; Interferon alfa-2a biosimilar - Rhein Minapharm Biogenetics; ReiferonLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Rhein Minapharm Biogenetics
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis C
Most Recent Events
- 31 Dec 2005 Launched for Hepatitis C in Egypt (SC)